CORE LABORATORIES N V Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenue
Service
Product
Total revenue
OPERATING EXPENSES:
Cost of services, exclusive of depreciation shown below
Cost of product sales, exclusive of depreciation shown below
Cost of services and product sales exclusive of depreciation expense and inventory write-down shown below
Service
Product
General and administrative expense, exclusive of depreciation expense shown below
Depreciation
Amortization
Impairments and other charges
Inventory write-down
Other (income) expense, net

OPERATING INCOME
OPERATING INCOME (LOSS)
Interest expense
Income (loss) from continuing operations before income taxes
Income tax expense (benefit)
Income from continuing operations
Income (loss) from discontinued operations
Income (loss) from continuing operations
Income (loss) from discontinued operations, net of income taxes
Net income (loss)
Net income (loss) attributable to non-controlling interest
Net income (loss) attributable to Core Laboratories N.V.
EARNINGS (LOSS) PER SHARE INFORMATION:
Basic earnings (loss) per share from continuing operations
Basic earnings (loss) per share from discontinued operations
Basic earnings (loss) per share attributable to Core Laboratories N.V.
Diluted earnings (loss) per share from continuing operations
Diluted earnings (loss) per share from discontinued operations
Diluted earnings (loss) per share attributable to Core Laboratories N.V.
Cash dividends per share (in dollar per share)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)
Diluted (in shares)

Comments